Pharmaceutical composition based on 2′-deoxy-2′-(aminocarbamoyl)guanosine and muramidase (lysozyme).
Abstract
Using lysozyme in combination with your modified nucleoside 2′-deoxy-2′-(aminocarbonyl)guanosine (hereinafter referred to as 2′-carbamoyl-2′-deoxyguanosine) is a strategic move. Combination therapies combining small molecules (nucleoside analogues) and antimicrobial enzymes are seen as one of the most promising ways to overcome pathogen resistance.
Fields of Study & Subjects
Biochemical and Molecular Research
Cancer Research and Treatments
Enzyme Structure and Function
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 1 January 2026